Pulmonx
LUNG
118 hedge funds and large institutions have $244M invested in Pulmonx in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 15 closing their positions.
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
4% more funds holding
Funds holding: 113 → 118 (+5)
6% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 90.84% → 90.84% (-0%)
17% less capital invested
Capital invested by funds: $294M → $244M (-$50.2M)
100% less call options, than puts
Call options by funds: $4K | Put options by funds: $1.74M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$10.1M |
| 2 |
ACM
Altium Capital Management
New York
|
+$2.07M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.19M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$906K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$653K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.72M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.06M |
| 3 |
JP Morgan Chase
New York
|
-$1.89M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.44M |
| 5 |
Primecap Management
Pasadena,
California
|
-$1.08M |
LUNG Hedge Fund Activity: Q4 2024 in Review
118 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2024, worth a combined $244M — down 17% from $294M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LUNG positions and 15 closed out — a net gain of 8 holders — while 36 added to existing stakes and 34 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $10.1M. The largest seller was Morgan Stanley, cutting an estimated $4.72M.
- 118 institutional investors held Pulmonx (LUNG) as of Q4 2024, up from 113 in Q3 2024.
- Funds reported $244M of Pulmonx stock for Q4 2024, down 17% quarter-over-quarter.
- 23 funds opened new Pulmonx positions in Q4 2024 and 15 closed out, a net change of +8 holders.
- The largest Pulmonx buyer in Q4 2024 was Deerfield Management, an estimated $10.1M added.
- The largest Pulmonx seller in Q4 2024 was Morgan Stanley, an estimated $4.72M sold.
Based on aggregated 13F filings for Q4 2024.